Show
Sort by
-
Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT) : a prospective study from the Belgian Hematology Society (BHS)
-
Use of chimerism analysis after allogeneic stem cell transplantation : Belgian guidelines and review of the current literature
-
- Journal Article
- A1
- open access
Inferior outcome of addition of the aminopeptidase inhibitor tosedostat to standard intensive treatment for elderly patients with AML and high risk MDS
-
- Journal Article
- A1
- open access
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : the HOVON-SAKK-132 trial
-
- Journal Article
- A1
- open access
How to make an immune system and a foreign host quickly cohabit in peace? The challenge of acute graft-versus-host disease prevention after allogeneic hematopoietic cell transplantation
-
Multipotent mesenchymal stromal cells for poor graft function after allogeneic hematopoietic cell transplantation : a multicenter prospective study
-
Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres
-
A national multi-center randomized study to assess the accuracy, reliability, and user satisfaction of the Ebmt GvHD App in graft versus host disease assessment
-
- Journal Article
- A1
- open access
The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment : a multicenter randomized controlled trial
-
- Journal Article
- A1
- open access
Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society